Is BDX a good stock to buy? We came across a bullish thesis on Becton, Dickinson and Company on The Mispricing Desk’s Substack. In this article, we will summarize the bulls’ thesis on BDX. Becton, Dickinson and Company's share was trading at $149.99 as of June 8th. BDX’s trailing and forward P/E were 26.38 and 11.21 respectively according to Yahoo Finance.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories,...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.